FIELD: medicine.
SUBSTANCE: treating infantile and child's active atopic dermatitis is combined with determining the child's blood serum complement component C3, interleukin 6 and interleukin 10 concentrations. If the complement component C3 concentration is less than 0.8 mg/ml, while the interleukin 6 concentration is more than 20.9 ng/ml and the interleukin 10 concentration is more than 5.6 ng/ml, the developing infectious complication of atopic dermatitis in a child is predicted.
EFFECT: predictable developing therapeutic infectious complications of the infantile and child's active atopic dermatitis.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF INFECTIOUS COMPLICATIONS OF ATOPIC DERMATITIS FOR CHILDREN IN CASE OF SPECIFIC IMMUNOTHERAPY | 2015 |
|
RU2613301C1 |
| METHOD FOR PREDICTING SEVERITY OF ATOPIC DERMATITIS IN CHILDREN WITH ACCOMPANYING INTESTINAL DYSBACTERIOSIS | 2018 |
|
RU2692803C1 |
| METHOD FOR PREDICTION OF SEVERITY OF ATOPIC DERMATITIS IN CHILDREN | 2019 |
|
RU2711746C1 |
| METHOD FOR PREDICTION OF SEVERITY OF ATOPIC DERMATITIS IN CHILDREN | 2017 |
|
RU2677481C1 |
| METHOD OF PREDICTING DEGREE OF ATOPIC DERMATITIS IN CHILDREN | 2016 |
|
RU2630063C1 |
| METHOD FOR PREDICTION OF LINGERING VIRAL HEPATITIS A IN CHILDREN WITH FOOD ALLERGY | 2008 |
|
RU2382363C1 |
| METHOD FOR PREDICTION OF THE RISK OF INFECTIOUS COMPLICATIONS IN ATOPIC DERMATITIS | 2018 |
|
RU2694223C1 |
| METHOD FOR PREDICTION OF CHILDREN ATOPIC DERMATITIS RISK | 2019 |
|
RU2703546C1 |
| METHOD FOR PREDICTION OF RISK OF INFECTIOUS COMPLICATIONS DEVELOPMENT IN ATOPIC DERMATITIS | 2020 |
|
RU2738722C1 |
| DIAGNOSTIC TECHNIQUE FOR ATOPIC DERMATITIS IN CHILDREN | 2011 |
|
RU2461828C1 |
